• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我如何处理抗凝相关出血或紧急手术的患者。

How I manage patients with anticoagulation-associated bleeding or urgent surgery.

作者信息

Sauter Thomas C, Eberle Balthasar, Wuillemin Walter A, Thiele Thomas, Angelillo-Scherrer Anne, Exadaktylos Aristomenis K, Erdoes Gabor, Cuker Adam, Nagler Michael

机构信息

Department of Emergency Medicine, Inselspital, University Hospital Bern, Switzerland.

Department of Anaesthesiology and Pain Therapy, Inselspital, University Hospital Bern, Switzerland.

出版信息

Swiss Med Wkly. 2018 Mar 14;148:w14598. doi: 10.4414/smw.2018.14598. eCollection 2018.

DOI:10.4414/smw.2018.14598
PMID:29538795
Abstract

Antithrombotic treatment puts patients at risk of major bleeding. Fast and adequate response to anticoagulant-associated bleeding may not only stop the bleeding but prevent severe complications. However, practical treatment algorithms to guide physicians in emergency situations are lacking. Important principles that arise from management of bleeding in general are (a) implementation of an in-house algorithm, (b) rapid identification and treatment of the bleeding source, (c) adequate fluid resuscitation, (d) consideration of the application of tranexamic acid and (e) appropriate coagulation testing. We present an algorithm for anticoagulant-associated bleeding and urgent surgery, derived from available data and recommendations, and implemented at our institution. Decisions regarding reversal agents or postponing surgery are based on two questions: the occurrence of a life-threatening bleed or urgent indication for surgery, and the presence of a relevant drug level. Immediate application of reversal agents is suggested if the clinical situation is urgent and laboratory test results are delayed or unavailable. A relevant anticoagulant drug level is required in all other cases. We discuss appropriate laboratory assays for all commonly available anticoagulants, report respective target ranges or expected values, discuss time intervals before surgery, and present critical cut-off values to be used as decision criteria. Specific and unspecific reversal agents for all anticoagulants including the direct oral anticoagulants will be presented. We aim to provide practical guidance for physicians in emergency situations. In addition, we summarise and discuss available experimental and clinical data as well as recommendations provided by scientific societies, authorities and manufacturers.

摘要

抗栓治疗会使患者面临大出血风险。对抗凝相关出血做出快速且充分的反应不仅可以止血,还能预防严重并发症。然而,目前缺乏在紧急情况下指导医生的实用治疗方案。一般出血管理中出现的重要原则包括:(a)实施院内方案;(b)快速识别并治疗出血源;(c)充分的液体复苏;(d)考虑应用氨甲环酸;(e)进行适当的凝血检测。我们根据现有数据和建议,提出了一种用于抗凝相关出血和紧急手术的方案,并已在我们机构实施。关于使用逆转剂或推迟手术的决策基于两个问题:是否发生危及生命的出血或手术的紧急指征,以及是否存在相关药物水平。如果临床情况紧急且实验室检测结果延迟或无法获得,建议立即应用逆转剂。在所有其他情况下,都需要有相关的抗凝药物水平。我们讨论了所有常用抗凝剂的适当实验室检测方法,报告了各自的目标范围或预期值,讨论了手术前的时间间隔,并给出了用作决策标准的临界值。还将介绍包括直接口服抗凝剂在内的所有抗凝剂的特异性和非特异性逆转剂。我们旨在为紧急情况下的医生提供实用指导。此外,我们总结并讨论了现有的实验和临床数据以及科学协会、权威机构和制造商提供的建议。

相似文献

1
How I manage patients with anticoagulation-associated bleeding or urgent surgery.我如何处理抗凝相关出血或紧急手术的患者。
Swiss Med Wkly. 2018 Mar 14;148:w14598. doi: 10.4414/smw.2018.14598. eCollection 2018.
2
Managing reversal of direct oral anticoagulants in emergency situations. Anticoagulation Education Task Force White Paper.管理紧急情况下直接口服抗凝剂的逆转。抗凝教育工作组白皮书。
Thromb Haemost. 2016 Nov 30;116(6):1003-1010. doi: 10.1160/TH16-05-0363. Epub 2016 Aug 4.
3
Managing bleeding and emergency reversal of newer oral anticoagulants: a review for primary care providers.新型口服抗凝剂的出血管理与紧急逆转:面向初级保健提供者的综述
Hosp Pract (1995). 2014 Oct;42(4):75-82. doi: 10.3810/hp.2014.10.1144.
4
Management of Elective Surgery and Emergent Bleeding with Direct Oral Anticoagulants.直接口服抗凝剂治疗择期手术和急症出血的管理。
Curr Cardiol Rep. 2017 Oct 24;19(12):124. doi: 10.1007/s11886-017-0930-2.
5
Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.长期接受直接口服抗凝剂、凝血酶或因子 Xa 抑制剂治疗的患者的大出血并发症和紧急手术的处理:围手术期止血工作组(GIHP)的建议-2013 年 3 月。
Arch Cardiovasc Dis. 2013 Jun-Jul;106(6-7):382-93. doi: 10.1016/j.acvd.2013.04.009. Epub 2013 Jun 25.
6
Factor Eight Inhibitor Bypassing Agent (FEIBA) for Reversal of Target-Specific Oral Anticoagulants in Life-Threatening Intracranial Bleeding.用于逆转危及生命的颅内出血中靶向特异性口服抗凝剂的凝血因子Ⅷ抑制剂旁路制剂(FEIBA)
J Emerg Med. 2017 May;52(5):731-737. doi: 10.1016/j.jemermed.2016.11.011. Epub 2016 Dec 19.
7
Monitoring and reversal strategies for new oral anticoagulants.新型口服抗凝剂的监测与逆转策略
Expert Rev Cardiovasc Ther. 2015 Jan;13(1):95-103. doi: 10.1586/14779072.2015.987126. Epub 2014 Nov 28.
8
Reversal Strategies for Newer Oral Anticoagulants.新型口服抗凝药的逆转策略
AACN Adv Crit Care. 2017 Winter;28(4):322-331. doi: 10.4037/aacnacc2017744.
9
Reversal of anticoagulants: an overview of current developments.抗凝剂的逆转:当前进展概述
Thromb Haemost. 2015 May;113(5):931-42. doi: 10.1160/TH14-11-0982. Epub 2015 Apr 2.
10
Current state of knowledge on oral anticoagulant reversal using procoagulant factors.目前关于使用促凝血因子逆转口服抗凝剂的知识状况。
Ann Pharmacother. 2013 Jun;47(6):841-55. doi: 10.1345/aph.1R724. Epub 2013 May 21.

引用本文的文献

1
Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban Calibrator.使用通用依度沙班校准品测定抗Xa抑制剂血浆浓度
Diagnostics (Basel). 2023 Jun 20;13(12):2128. doi: 10.3390/diagnostics13122128.
2
PROTHROMBIN COMPLEX CONCENTRATE 
IN EMERGENCY DEPARTMENT.人凝血酶原复合物在急诊科的应用。
Acta Clin Croat. 2022 Jun;61(Suppl 1):53-58. doi: 10.20471/acc.2022.61.s1.09.
3
Prothrombinase-Induced Clotting Time to Measure Drug Concentrations of Rivaroxaban, Apixaban, and Edoxaban in Clinical Practice: A Cross-Sectional Study.
凝血酶原酶诱导凝血时间用于测定临床实践中利伐沙班、阿哌沙班和依度沙班的药物浓度:一项横断面研究。
Life (Basel). 2022 Jul 11;12(7):1027. doi: 10.3390/life12071027.
4
Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional Study.用于测量利伐沙班、阿哌沙班和依度沙班药物浓度的单一肝素校准抗Xa测定法的准确性:一项前瞻性横断面研究。
Front Cardiovasc Med. 2022 Mar 17;9:817826. doi: 10.3389/fcvm.2022.817826. eCollection 2022.
5
Automated Thrombin Generation Assay for Rivaroxaban, Apixaban, and Edoxaban Measurements.用于利伐沙班、阿哌沙班和依度沙班测定的自动凝血酶生成测定法。
Front Cardiovasc Med. 2021 Sep 9;8:717939. doi: 10.3389/fcvm.2021.717939. eCollection 2021.
6
A universal anti-Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validation.一种用于利伐沙班、阿哌沙班和依度沙班测量的通用抗 Xa 检测法:方法验证、诊断准确性和外部验证。
Br J Haematol. 2021 Jun;193(6):1203-1212. doi: 10.1111/bjh.17470. Epub 2021 May 6.
7
Severe Enoral Bleeding with a Direct Oral Anticoagulant after Tooth Extraction and Heparin Bridging Treatment.拔牙及肝素桥接治疗后使用直接口服抗凝剂导致严重口腔出血
Case Rep Emerg Med. 2019 Oct 29;2019:6208604. doi: 10.1155/2019/6208604. eCollection 2019.
8
Application of prothrombin complex concentrate for reversal of direct oral anticoagulants in clinical practice: indications, patient characteristics and clinical outcomes compared to reversal of vitamin K antagonists.临床实践中凝血酶原复合物浓缩物逆转直接口服抗凝剂的应用:与维生素 K 拮抗剂逆转相比的适应证、患者特征和临床结局。
Scand J Trauma Resusc Emerg Med. 2019 Apr 23;27(1):48. doi: 10.1186/s13049-019-0625-3.